Revisions of General Guidelines for the Preclinical Toxicology of New Cytotoxic Anticancer Agents in Europe

Author: Cancer Research Campaign CRC Phase I/II Clinical Trials Committee and the European Organization for Research and Treatment of Cancer EORTC New Drug Development Office   Burtles S.S.   Newell D.R.   Henrar R.E.C.   Connors T.A.  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.31, Iss.3, 1995-01, pp. : 408-410

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract